Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID‐19: A collision of complement, coagulation and inflammatory pathways
Anoop Chauhan, Laura Wiffen, Thomas Brown
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 9, pp. 2110-2117
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms
Joan Loo, Daniella A. Spittle, Michael Newnham
Thorax (2021) Vol. 76, Iss. 4, pp. 412-420
Open Access | Times Cited: 321
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Peter Garred, Andrea J. Tenner, Tom Eirik Mollnes
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 792-827
Open Access | Times Cited: 134
Proposal of the Definition for COVID-19-Associated Coagulopathy
Toshiaki Iba, Theodore E. Warkentin, Jecko Thachil, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 191-191
Open Access | Times Cited: 124
The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals
Carlos A. Cañas
Medical Hypotheses (2020) Vol. 145, pp. 110345-110345
Open Access | Times Cited: 102
Characteristics of coagulation alteration in patients with COVID-19
Hong-chun Luo, Cheng-yan You, Si-wei Lu, et al.
Annals of Hematology (2020) Vol. 100, Iss. 1, pp. 45-52
Open Access | Times Cited: 77
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients
Joram Huckriede, Sara Bülow Anderberg, Albert Morales, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 71
Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening
Yuan Xiong, Guanghao Zhu, Haonan Wang, et al.
Fitoterapia (2021) Vol. 152, pp. 104909-104909
Open Access | Times Cited: 67
Endothelial cells and SARS-CoV-2: An intimate relationship
Lucas Cunha Barbosa, Thaynan Lopes Gonçalves, Luanna Prudencio de Araújo, et al.
Vascular Pharmacology (2021) Vol. 137, pp. 106829-106829
Open Access | Times Cited: 66
Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
Bandar Alosaimi, Ayman Mubarak, Maaweya E. Hamed, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 65
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19
Paôline Laurent, Chao Yang, André F. Rendeiro, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 61
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Yaaser Q. Almulaiky, et al.
European Journal of Pharmacology (2021) Vol. 904, pp. 174196-174196
Open Access | Times Cited: 60
Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 47
Tissue factor in COVID-19-associated coagulopathy
Saravanan Subramaniam, Hema Kothari, Markus Bosmann
Thrombosis Research (2022) Vol. 220, pp. 35-47
Open Access | Times Cited: 39
The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics
Manaswini Ghosh, Soumendra Rana
International Immunopharmacology (2023) Vol. 118, pp. 110081-110081
Closed Access | Times Cited: 28
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
Wioleta M. Zelek, R. A. Harrison
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152393-152393
Open Access | Times Cited: 28
A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View
Hamid Soltani Zangbar, Ali Gorji, Tahereh Ghadiri
Molecular Neurobiology (2020) Vol. 58, Iss. 2, pp. 536-549
Open Access | Times Cited: 54
SARS-CoV-2 involvement in central nervous system tissue damage
Mirna Sabra, Firas Kobeissy, Maya Bizri, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 6, pp. 1228-1228
Open Access | Times Cited: 49
Autoimmune hemolytic anemia: causes and consequences
Bruno Fattizzo, Wilma Barcellini
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 7, pp. 731-745
Open Access | Times Cited: 35
Neutrophil autophagy and NETosis in COVID-19: perspectives
Ruoyu Zhang, Chen Sun, Yunze Han, et al.
Autophagy (2022) Vol. 19, Iss. 3, pp. 758-767
Open Access | Times Cited: 35
The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System
Anna S. Świerzko, Maciej Cedzyński
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 48
Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways
Zeinab Amini‐Farsani, Mahtab Yadollahi‐Farsani, Samaneh Arab, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108071-108071
Open Access | Times Cited: 36
Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism
Firdos Ahmad, Meganathan Kannan, Abdul W. Ansari
Cytokine & Growth Factor Reviews (2021) Vol. 63, pp. 58-68
Open Access | Times Cited: 35
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19
Matthew K. Siggins, Kate Davies, R.J. Fellows, et al.
Immunology (2022) Vol. 168, Iss. 3, pp. 473-492
Open Access | Times Cited: 28
Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease
Bahman Yousefi, Seyedeh Zahra Banihashemian, Zahra Khatibiyan Feyzabadi, et al.
Medical Gas Research (2022) Vol. 12, Iss. 2, pp. 33-40
Open Access | Times Cited: 27
COVID-19 and Anemia: What Do We Know So Far?
Luai Abu‐Ismail, Mohammad J. J. Taha, Mohammad T. Abuawwad, et al.
Hemoglobin (2023) Vol. 47, Iss. 3, pp. 122-129
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top